nifedipine has been researched along with thiophenes in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (23.08) | 18.2507 |
2000's | 4 (30.77) | 29.6817 |
2010's | 6 (46.15) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duffy, EM; Jorgensen, WL | 1 |
Eda, T; Hidaka, Y; Kamei, T; Yonemoto, M | 1 |
Duckles, SP; Friedman, DJ | 2 |
Görlitzer, K; Meyer, H | 1 |
Aalkjaer, C; Bek, T; Hessellund, A; Holmgaard, K; Torring, MS | 1 |
Albert, DH; Banfor, PN; Cox, BF; Davidsen, SK; Franklin, PH; Fryer, RM; Gintant, GA; Larson, KJ; Noonan, WT; Segreti, JA; Tapang, P; Widomski, DL | 1 |
Dhaun, N; Goddard, J; Haughie, S; Johnston, NR; Kerr, D; MacIntyre, IM; Melville, V; Webb, DJ | 1 |
Blackwell, S; Dhaun, N; Goddard, J; Johnston, NR; Melville, V; Talwar, DK; Webb, DJ | 1 |
Cortizo, AM; Fernández, JM; McCarthy, AD; Molinuevo, MS; Schurman, L; Sedlinsky, C | 2 |
Okada, J; Okada, S; Saito, T; Satoh, T; Shibusawa, R; Shimoda, Y; Tagaya, Y; Yamada, E; Yamada, M | 1 |
Chariyavilaskul, P; Corder, R; Dhaun, N; Goddard, J; Kimmitt, RA; MacIntyre, IM; Webb, DJ; Wood, EG; Yuzugulen, J | 1 |
3 trial(s) available for nifedipine and thiophenes
Article | Year |
---|---|
Selective endothelin-A receptor antagonism reduces proteinuria, blood pressure, and arterial stiffness in chronic proteinuric kidney disease.
Topics: Adult; Antihypertensive Agents; Arteries; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Endothelin A Receptor Antagonists; Female; Glomerular Filtration Rate; Humans; Hypertension; Isoxazoles; Kidney Failure, Chronic; Male; Middle Aged; Nifedipine; Proteinuria; Radioimmunoassay; Thiophenes; Treatment Outcome; Vascular Resistance; Vasodilator Agents | 2011 |
Endothelin-A receptor antagonism modifies cardiovascular risk factors in CKD.
Topics: Adult; Biomarkers; Blood Pressure; Cardiovascular Diseases; Cross-Over Studies; Double-Blind Method; Endothelin Receptor Antagonists; Endothelin-1; Female; Humans; Isoxazoles; Male; Middle Aged; Nifedipine; Proteinuria; Pulse Wave Analysis; Renal Insufficiency, Chronic; Thiophenes; Vascular Stiffness; Vasodilator Agents | 2013 |
Plasma pro-endothelin-1 peptide concentrations rise in chronic kidney disease and following selective endothelin A receptor antagonism.
Topics: Adult; Biomarkers; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Double-Blind Method; Endothelin A Receptor Antagonists; Endothelin-1; Female; Humans; Isoxazoles; Male; Middle Aged; Nifedipine; Protein Precursors; Proteinuria; Receptor, Endothelin A; Renal Insufficiency, Chronic; Scotland; Thiophenes; Time Factors; Treatment Outcome; Up-Regulation; Vascular Stiffness | 2015 |
10 other study(ies) available for nifedipine and thiophenes
Article | Year |
---|---|
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
Inhibition of cultured vascular smooth muscle cell migration by simvastatin (MK-733).
Topics: Animals; Anticholesteremic Agents; Aorta, Thoracic; Benzylamines; Cell Movement; Cells, Cultured; Dose-Response Relationship, Drug; Fibrinogen; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Lovastatin; Mevalonic Acid; Muscle, Smooth, Vascular; Nifedipine; Platelet-Derived Growth Factor; Pravastatin; Simvastatin; Sterols; Swine; Thiophenes | 1992 |
Influence of age on control of norepinephrine release: Ca2+ channels and dopamine D2 receptors.
Topics: Aging; Animals; Arteries; Calcium Channel Blockers; Calcium Channels; Dopamine Agents; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Norepinephrine; omega-Conotoxin GVIA; Peptides; Rats; Rats, Inbred F344; Receptors, Dopamine D2; Sympathetic Nervous System; Tail; Tetrahydronaphthalenes; Thiophenes | 1994 |
Effect of calcium channel blockers on norepinephrine release and modulation by prejunctional D2 dopamine receptors.
Topics: Animals; Arteries; Calcium Channel Blockers; Calcium Channels; Dopamine Agents; Electric Stimulation; Male; Nifedipine; Norepinephrine; omega-Conotoxins; Peptides; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Tetrahydronaphthalenes; Thiophenes | 1994 |
[Bisbenzothieno[3,2-b: 2',3'-e]pyridines].
Topics: Acetates; Decarboxylation; Dihydropyridines; Indicators and Reagents; Magnetic Resonance Spectroscopy; Nifedipine; Oxidants; Pyridines; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Thiophenes | 2004 |
The vasodilating effect of acetazolamide and dorzolamide involves mechanisms other than carbonic anhydrase inhibition.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetazolamide; Acidosis; Animals; Arterioles; Carbon Dioxide; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Dose-Response Relationship, Drug; Hydrogen-Ion Concentration; Hypercapnia; Muscle, Smooth, Vascular; Myography; Nifedipine; Retinal Artery; Sulfonamides; Swine; Thiophenes; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2009 |
Effect of the multitargeted receptor tyrosine kinase inhibitor, ABT-869 [N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea], on blood pressure in conscious rats and mice: reversal with antihypertensive agents and effect on tumor growt
Topics: Acrylates; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Enalapril; Humans; Imidazoles; Indazoles; Lisinopril; Male; Mice; Mice, SCID; Neoplasms; Nifedipine; Phenylurea Compounds; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Ramipril; Rats; Rats, Sprague-Dawley; Telmisartan; Thiophenes; Xenograft Model Antitumor Assays | 2009 |
Strontium ranelate prevents the deleterious action of advanced glycation endproducts on osteoblastic cells via calcium channel activation.
Topics: Alkaline Phosphatase; Animals; beta Catenin; Bone Density Conservation Agents; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Differentiation; Cell Line; Cell Proliferation; Collagen Type I; Extracellular Signal-Regulated MAP Kinases; Glycation End Products, Advanced; Interleukin-1beta; Mice; Nifedipine; Osteoblasts; Thiophenes; Tumor Necrosis Factor-alpha | 2013 |
Glycosuria medicated with ipragliflozin and nifedipine or ipragliflozin and candesartan: a case report.
Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Drug Therapy, Combination; Glucosides; Glycosuria; Humans; Male; Middle Aged; Nifedipine; Tetrazoles; Thiophenes; Treatment Outcome | 2014 |
Advanced glycation end products and strontium ranelate promote osteogenic differentiation of vascular smooth muscle cells in vitro: Preventive role of vitamin D.
Topics: Animals; Ascorbic Acid; Cell Count; Cell Differentiation; Cell Movement; Core Binding Factor Alpha 1 Subunit; Glycation End Products, Advanced; Male; Models, Biological; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nifedipine; Osteogenesis; Oxidative Stress; Rats, Sprague-Dawley; Reactive Oxygen Species; Sulfasalazine; Thiophenes; Vitamin D; Vitamin E | 2017 |